Loading…
Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells
Rhabdomyosarcoma is the most common soft tissue sarcoma in the pediatric population. As this tumor has an undifferentiated myogenic phenotype, agents that promote differentiation hold particular promise as part of a novel therapeutic approach to combat this type of cancer. In this report, we focus o...
Saved in:
Published in: | The FASEB journal 2010-09, Vol.24 (9), p.3427-3437 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5228-33693727303e24af71754039ba716479e4083d2523aff7d91acd9fdff1d07303 |
---|---|
cites | cdi_FETCH-LOGICAL-c5228-33693727303e24af71754039ba716479e4083d2523aff7d91acd9fdff1d07303 |
container_end_page | 3437 |
container_issue | 9 |
container_start_page | 3427 |
container_title | The FASEB journal |
container_volume | 24 |
creator | Rao, Prakash K Missiaglia, Edoardo Shields, Lauren Hyde, Greg Yuan, Bingbing Shepherd, Christopher J Shipley, Janet Lodish, Harvey F |
description | Rhabdomyosarcoma is the most common soft tissue sarcoma in the pediatric population. As this tumor has an undifferentiated myogenic phenotype, agents that promote differentiation hold particular promise as part of a novel therapeutic approach to combat this type of cancer. In this report, we focus on the contribution of two microRNAs (miRNAs) in rhabdomyosarcomas. Levels of miR-1 and miR-133a are drastically reduced in representative cell lines from each major rhabdomyosarcoma subtype (embryonal and alveolar). Introduction of miR-1 and miR-133a into an embryonal rhabdomyosarcoma-derived cell line is cytostatic, thereby suggesting a tumor suppressor-like role for these myogenic miRNAs. Transcriptional profiling of cells after miR-1 and miR-133a expression reveals that miR-1 (but not miR-133a) exerts a strong promyogenic influence on these poorly differentiated tumor cells. We identify mRNAs that are down-regulated by these miRNAs and propose roles for miR-1 and miR-133a in repressing isoforms of genes that are normally not expressed in muscle. Finally, we show that mRNA targets of miR-1 and miR-133a are up-regulated in rhabdomyosarcomas, suggesting a causative role for these miRNAs in the development of rhabdomyosarcomas. More important, these results point to the promise of enhancing rhabdomyosarcoma therapy using miRNAs as agents that mediate cytostasis and promote muscle differentiation.--Rao, P. K., Missiaglia, E., Shields, L., Hyde, G., Yuan, B., Shepherd, C. J., Shipley, J., Lodish, H. F. Distinct roles for Mir-1 and Mir-133a in the proliferation and differentiation of rhabdomyosarcoma cells. |
doi_str_mv | 10.1096/fj.09-150698 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3231107</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>754000599</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5228-33693727303e24af71754039ba716479e4083d2523aff7d91acd9fdff1d07303</originalsourceid><addsrcrecordid>eNp9kc1v1DAQxa0K1G4Xbj0X37g0ZWwnjn1BgpblQ5WQaDlbs7Hd9SqJFzvbav_7ZklZwYWTx57fvHnWI-SMwSUDLd_59SXoglUgtToiM1YJKKSS8ILMQGleSCnUCTnNeQ0ADJg8JiccSilVrWZkdR3yEPpmoCm2LlMfE-3Cj4JR7O1UCYE09HRYOboZoeBdwiHE_jdhgx_vrh_C9BY9TStc2tjtYsbUxA5p49o2vyIvPbbZvX4-5-Ru8enu6ktx8_3z16sPN0VTca4KIaQWNa8FCMdL9DWrqxKEXmLNZFlrV4ISlldcoPe11Qwbq731nlnYD83J-0l2s112zjajs4St2aTQYdqZiMH82-nDytzHByO4YGyUmJO3zwIp_tq6PJgu5P0PsHdxm83eDkCl9UheTGSTYs7J-cMWBmYfjfFrA9pM0Yz4-d_ODvCfLEZATcBjaN3uv2JmcfuRL76BPmi_mUY9RoP3KWTz85YDE8CUKrXi4glfhaQP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>754000599</pqid></control><display><type>article</type><title>Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Rao, Prakash K ; Missiaglia, Edoardo ; Shields, Lauren ; Hyde, Greg ; Yuan, Bingbing ; Shepherd, Christopher J ; Shipley, Janet ; Lodish, Harvey F</creator><creatorcontrib>Rao, Prakash K ; Missiaglia, Edoardo ; Shields, Lauren ; Hyde, Greg ; Yuan, Bingbing ; Shepherd, Christopher J ; Shipley, Janet ; Lodish, Harvey F</creatorcontrib><description>Rhabdomyosarcoma is the most common soft tissue sarcoma in the pediatric population. As this tumor has an undifferentiated myogenic phenotype, agents that promote differentiation hold particular promise as part of a novel therapeutic approach to combat this type of cancer. In this report, we focus on the contribution of two microRNAs (miRNAs) in rhabdomyosarcomas. Levels of miR-1 and miR-133a are drastically reduced in representative cell lines from each major rhabdomyosarcoma subtype (embryonal and alveolar). Introduction of miR-1 and miR-133a into an embryonal rhabdomyosarcoma-derived cell line is cytostatic, thereby suggesting a tumor suppressor-like role for these myogenic miRNAs. Transcriptional profiling of cells after miR-1 and miR-133a expression reveals that miR-1 (but not miR-133a) exerts a strong promyogenic influence on these poorly differentiated tumor cells. We identify mRNAs that are down-regulated by these miRNAs and propose roles for miR-1 and miR-133a in repressing isoforms of genes that are normally not expressed in muscle. Finally, we show that mRNA targets of miR-1 and miR-133a are up-regulated in rhabdomyosarcomas, suggesting a causative role for these miRNAs in the development of rhabdomyosarcomas. More important, these results point to the promise of enhancing rhabdomyosarcoma therapy using miRNAs as agents that mediate cytostasis and promote muscle differentiation.--Rao, P. K., Missiaglia, E., Shields, L., Hyde, G., Yuan, B., Shepherd, C. J., Shipley, J., Lodish, H. F. Distinct roles for Mir-1 and Mir-133a in the proliferation and differentiation of rhabdomyosarcoma cells.</description><identifier>ISSN: 0892-6638</identifier><identifier>EISSN: 1530-6860</identifier><identifier>DOI: 10.1096/fj.09-150698</identifier><identifier>PMID: 20466878</identifier><language>eng</language><publisher>United States: The Federation of American Societies for Experimental Biology</publisher><subject>Cell Differentiation - genetics ; Cell Line, Tumor ; Cell Proliferation ; Gene Expression Profiling ; Humans ; microRNA ; MicroRNAs - genetics ; MicroRNAs - metabolism ; muscle ; Research Communications ; Rhabdomyosarcoma - genetics ; Rhabdomyosarcoma - pathology ; tumor</subject><ispartof>The FASEB journal, 2010-09, Vol.24 (9), p.3427-3437</ispartof><rights>FASEB</rights><rights>2010 FASEB 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5228-33693727303e24af71754039ba716479e4083d2523aff7d91acd9fdff1d07303</citedby><cites>FETCH-LOGICAL-c5228-33693727303e24af71754039ba716479e4083d2523aff7d91acd9fdff1d07303</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20466878$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rao, Prakash K</creatorcontrib><creatorcontrib>Missiaglia, Edoardo</creatorcontrib><creatorcontrib>Shields, Lauren</creatorcontrib><creatorcontrib>Hyde, Greg</creatorcontrib><creatorcontrib>Yuan, Bingbing</creatorcontrib><creatorcontrib>Shepherd, Christopher J</creatorcontrib><creatorcontrib>Shipley, Janet</creatorcontrib><creatorcontrib>Lodish, Harvey F</creatorcontrib><title>Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells</title><title>The FASEB journal</title><addtitle>FASEB J</addtitle><description>Rhabdomyosarcoma is the most common soft tissue sarcoma in the pediatric population. As this tumor has an undifferentiated myogenic phenotype, agents that promote differentiation hold particular promise as part of a novel therapeutic approach to combat this type of cancer. In this report, we focus on the contribution of two microRNAs (miRNAs) in rhabdomyosarcomas. Levels of miR-1 and miR-133a are drastically reduced in representative cell lines from each major rhabdomyosarcoma subtype (embryonal and alveolar). Introduction of miR-1 and miR-133a into an embryonal rhabdomyosarcoma-derived cell line is cytostatic, thereby suggesting a tumor suppressor-like role for these myogenic miRNAs. Transcriptional profiling of cells after miR-1 and miR-133a expression reveals that miR-1 (but not miR-133a) exerts a strong promyogenic influence on these poorly differentiated tumor cells. We identify mRNAs that are down-regulated by these miRNAs and propose roles for miR-1 and miR-133a in repressing isoforms of genes that are normally not expressed in muscle. Finally, we show that mRNA targets of miR-1 and miR-133a are up-regulated in rhabdomyosarcomas, suggesting a causative role for these miRNAs in the development of rhabdomyosarcomas. More important, these results point to the promise of enhancing rhabdomyosarcoma therapy using miRNAs as agents that mediate cytostasis and promote muscle differentiation.--Rao, P. K., Missiaglia, E., Shields, L., Hyde, G., Yuan, B., Shepherd, C. J., Shipley, J., Lodish, H. F. Distinct roles for Mir-1 and Mir-133a in the proliferation and differentiation of rhabdomyosarcoma cells.</description><subject>Cell Differentiation - genetics</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation</subject><subject>Gene Expression Profiling</subject><subject>Humans</subject><subject>microRNA</subject><subject>MicroRNAs - genetics</subject><subject>MicroRNAs - metabolism</subject><subject>muscle</subject><subject>Research Communications</subject><subject>Rhabdomyosarcoma - genetics</subject><subject>Rhabdomyosarcoma - pathology</subject><subject>tumor</subject><issn>0892-6638</issn><issn>1530-6860</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kc1v1DAQxa0K1G4Xbj0X37g0ZWwnjn1BgpblQ5WQaDlbs7Hd9SqJFzvbav_7ZklZwYWTx57fvHnWI-SMwSUDLd_59SXoglUgtToiM1YJKKSS8ILMQGleSCnUCTnNeQ0ADJg8JiccSilVrWZkdR3yEPpmoCm2LlMfE-3Cj4JR7O1UCYE09HRYOboZoeBdwiHE_jdhgx_vrh_C9BY9TStc2tjtYsbUxA5p49o2vyIvPbbZvX4-5-Ru8enu6ktx8_3z16sPN0VTca4KIaQWNa8FCMdL9DWrqxKEXmLNZFlrV4ISlldcoPe11Qwbq731nlnYD83J-0l2s112zjajs4St2aTQYdqZiMH82-nDytzHByO4YGyUmJO3zwIp_tq6PJgu5P0PsHdxm83eDkCl9UheTGSTYs7J-cMWBmYfjfFrA9pM0Yz4-d_ODvCfLEZATcBjaN3uv2JmcfuRL76BPmi_mUY9RoP3KWTz85YDE8CUKrXi4glfhaQP</recordid><startdate>201009</startdate><enddate>201009</enddate><creator>Rao, Prakash K</creator><creator>Missiaglia, Edoardo</creator><creator>Shields, Lauren</creator><creator>Hyde, Greg</creator><creator>Yuan, Bingbing</creator><creator>Shepherd, Christopher J</creator><creator>Shipley, Janet</creator><creator>Lodish, Harvey F</creator><general>The Federation of American Societies for Experimental Biology</general><general>Federation of American Societies for Experimental Biology</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201009</creationdate><title>Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells</title><author>Rao, Prakash K ; Missiaglia, Edoardo ; Shields, Lauren ; Hyde, Greg ; Yuan, Bingbing ; Shepherd, Christopher J ; Shipley, Janet ; Lodish, Harvey F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5228-33693727303e24af71754039ba716479e4083d2523aff7d91acd9fdff1d07303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Cell Differentiation - genetics</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation</topic><topic>Gene Expression Profiling</topic><topic>Humans</topic><topic>microRNA</topic><topic>MicroRNAs - genetics</topic><topic>MicroRNAs - metabolism</topic><topic>muscle</topic><topic>Research Communications</topic><topic>Rhabdomyosarcoma - genetics</topic><topic>Rhabdomyosarcoma - pathology</topic><topic>tumor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rao, Prakash K</creatorcontrib><creatorcontrib>Missiaglia, Edoardo</creatorcontrib><creatorcontrib>Shields, Lauren</creatorcontrib><creatorcontrib>Hyde, Greg</creatorcontrib><creatorcontrib>Yuan, Bingbing</creatorcontrib><creatorcontrib>Shepherd, Christopher J</creatorcontrib><creatorcontrib>Shipley, Janet</creatorcontrib><creatorcontrib>Lodish, Harvey F</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The FASEB journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rao, Prakash K</au><au>Missiaglia, Edoardo</au><au>Shields, Lauren</au><au>Hyde, Greg</au><au>Yuan, Bingbing</au><au>Shepherd, Christopher J</au><au>Shipley, Janet</au><au>Lodish, Harvey F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells</atitle><jtitle>The FASEB journal</jtitle><addtitle>FASEB J</addtitle><date>2010-09</date><risdate>2010</risdate><volume>24</volume><issue>9</issue><spage>3427</spage><epage>3437</epage><pages>3427-3437</pages><issn>0892-6638</issn><eissn>1530-6860</eissn><abstract>Rhabdomyosarcoma is the most common soft tissue sarcoma in the pediatric population. As this tumor has an undifferentiated myogenic phenotype, agents that promote differentiation hold particular promise as part of a novel therapeutic approach to combat this type of cancer. In this report, we focus on the contribution of two microRNAs (miRNAs) in rhabdomyosarcomas. Levels of miR-1 and miR-133a are drastically reduced in representative cell lines from each major rhabdomyosarcoma subtype (embryonal and alveolar). Introduction of miR-1 and miR-133a into an embryonal rhabdomyosarcoma-derived cell line is cytostatic, thereby suggesting a tumor suppressor-like role for these myogenic miRNAs. Transcriptional profiling of cells after miR-1 and miR-133a expression reveals that miR-1 (but not miR-133a) exerts a strong promyogenic influence on these poorly differentiated tumor cells. We identify mRNAs that are down-regulated by these miRNAs and propose roles for miR-1 and miR-133a in repressing isoforms of genes that are normally not expressed in muscle. Finally, we show that mRNA targets of miR-1 and miR-133a are up-regulated in rhabdomyosarcomas, suggesting a causative role for these miRNAs in the development of rhabdomyosarcomas. More important, these results point to the promise of enhancing rhabdomyosarcoma therapy using miRNAs as agents that mediate cytostasis and promote muscle differentiation.--Rao, P. K., Missiaglia, E., Shields, L., Hyde, G., Yuan, B., Shepherd, C. J., Shipley, J., Lodish, H. F. Distinct roles for Mir-1 and Mir-133a in the proliferation and differentiation of rhabdomyosarcoma cells.</abstract><cop>United States</cop><pub>The Federation of American Societies for Experimental Biology</pub><pmid>20466878</pmid><doi>10.1096/fj.09-150698</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0892-6638 |
ispartof | The FASEB journal, 2010-09, Vol.24 (9), p.3427-3437 |
issn | 0892-6638 1530-6860 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3231107 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Cell Differentiation - genetics Cell Line, Tumor Cell Proliferation Gene Expression Profiling Humans microRNA MicroRNAs - genetics MicroRNAs - metabolism muscle Research Communications Rhabdomyosarcoma - genetics Rhabdomyosarcoma - pathology tumor |
title | Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-22T23%3A33%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Distinct%20roles%20for%20miR-1%20and%20miR-133a%20in%20the%20proliferation%20and%20differentiation%20of%20rhabdomyosarcoma%20cells&rft.jtitle=The%20FASEB%20journal&rft.au=Rao,%20Prakash%20K&rft.date=2010-09&rft.volume=24&rft.issue=9&rft.spage=3427&rft.epage=3437&rft.pages=3427-3437&rft.issn=0892-6638&rft.eissn=1530-6860&rft_id=info:doi/10.1096/fj.09-150698&rft_dat=%3Cproquest_pubme%3E754000599%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5228-33693727303e24af71754039ba716479e4083d2523aff7d91acd9fdff1d07303%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=754000599&rft_id=info:pmid/20466878&rfr_iscdi=true |